CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
Junshik Hong, Sun Young Kyung, Sang Pyo Lee, Jeong Woong Park, Sung Hwan Jung, Jae-Ik Lee, Se Hoon Park, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Korean J Intern Med. 2010;25(3):294-300.   Published online 2010 August 31    DOI: https://doi.org/10.3904/kjim.2010.25.3.294

Excel Download

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Yearbook of Oncology. 2012;2012:187-188   Crossref logo
Link1 Link2

Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
The Korean Journal of Internal Medicine. 2010;25(3):294   Crossref logo
Link1 Link2

Comparison of Gefitinib versus Docetaxel in Patients with Pre-Treated Non-Small Cell Lung Cancer (NSCLC)
Journal of Lung Cancer. 2009;8(2):61   Crossref logo
Link1 Link2 Link3

Erlotinib in-Previously Treated Non-Small-Cell Lung Cancer
Yearbook of Oncology. 2006;2006:231-233   Crossref logo
Link1 Link2

Erlotinib in Previously Treated Non-Small-Cell Lung Cancer
Yearbook of Pulmonary Disease. 2007;2007:144-146   Crossref logo
Link1 Link2

Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Thoracic Cancer. 2013;4(2):109-116   Crossref logo
Link1

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer
Current Medicine Research and Practice. 2016;6(2):96-97   Crossref logo
Link1 Link2

Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer
Lung Cancer. 2005;50(3):417-418   Crossref logo
Link1 Link2

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer
Lung Cancer. 2012;76(3):465-471   Crossref logo
Link1 Link2

9005 Vandetanib versus erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial
European Journal of Cancer Supplements. 2009;7(2):506   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.